Revvity Inc Quick Ratio (RVTY) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Revvity Inc  (NYSE: RVTY)

Revvity Inc's Quick Ratio

RVTY's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2026, Quick Ratio deteriorated to 0.63 below Revvity Inc's average Quick Ratio.

Within Laboratory Analytical Instruments industry 15 other companies have achieved higher Quick Ratio than Revvity Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 1394 to 2344.

Explain Quick Ratio?
How much Cash & cash equivalents RVTY´s has?
What are RVTY´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RVTY/financial-strength
https://api.csimarket.com/api/v1/companies/RVTY/fundamentals
https://api.csimarket.com/api/v1/companies/RVTY/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
RVTY Quick Ratio (Oct 04 2026)
Q3
(Jul 05 2026)
Q2
(Apr 05 2026)
Q1
(Dec 28 2025)
Q4
(Sep 28 2025)
Q3
Y / Y Current Liabilities Change -23.37 %
Y / Y Cash & cash equivalent Change -36.35 %
Quick Ratio MRQ 0.63
RVTY's Total Ranking # 2344
Seq. Current Liabilities Change -38.2 %
Seq. Cash & cash equivalent Change -42.05 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 16
Healthcare Sector # 702
Overall Market # 2344


Quick Ratio Statistics
High Average Low
3.82 0.98 0.2
(Oct 01 2017)   (Jan 03 2021)




Financial Statements
Revvity Inc's Current Liabilities $ 937 Millions Visit RVTY's Balance sheet
Revvity Inc's Cash & cash equivalent $ 593 Millions Visit RVTY's Balance sheet
Source of RVTY's Sales Visit RVTY's Sales by Geography


Cumulative Revvity Inc's Quick Ratio

RVTY's Quick Ratio for the trailling 12 Months

RVTY Quick Ratio

(Oct 04 2026)
12 Months
(Jul 05 2026)
12 Months
(Apr 05 2026)
12 Months
(Dec 28 2025)
12 Months
(Sep 28 2025)
12 Months
Y / Y Current Liabilities TTM Growth 57.17 %
Y / Y Cash & cash equivalent TTM Growth -19.61 %
Quick Ratio TTM 0.68
Total Ranking TTM # 1477
Seq. Current Liabilities TTM Growth -5.38 %
Seq. Cash & cash equivalent TTM Growth -9.07 %


On the trailing twelve months basis In spite of the year on year decrease in RVTY's Current Liabilities to $936.98 millions, cumulative Quick Ratio to 0.68 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Revvity Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2212 to 3998.

Explain Quick Ratio?
How much Cash & cash equivalents RVTY´s has?
What are RVTY´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 22
Healthcare Sector # 901
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
1.7 0.51 0.21
(Jun 29 2025)   (Jun 30 2019)




Companies with similar Quick Ratio in the quarter ending Oct 04 2026, within Laboratory Analytical Instruments Industry Quick RatioOct 04 2026 MRQ Cash & cash equivalentOct 04 2026 MRQ Current Liabilities
Quanterix Corporation  1.51 $ 77.359  Millions$ 51.130  Millions
Nautilus Biotechnology Inc   1.07 $ 10.467  Millions$ 9.758  Millions
Precipio inc   0.90 $ 3.576  Millions$ 3.985  Millions
Bio rad Laboratories Inc   0.86 $ 837.100  Millions$ 969.100  Millions
Bionano Genomics Inc   0.66 $ 8.168  Millions$ 12.307  Millions
Revvity Inc  0.63 $ 592.799  Millions$ 936.977  Millions
Avantor Inc   0.34 $ 464.300  Millions$ 1,369.000  Millions
Waters Corporation  0.27 $ 593.000  Millions$ 2,180.000  Millions
Harvard Bioscience Inc   0.19 $ 4.856  Millions$ 26.127  Millions

Date modified: 2026-11-12T05:50:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.